Therapeutic approaches for targeting receptor tyrosine kinase like orphan receptor-1 in cancer cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic approaches for targeting receptor tyrosine kinase like orphan receptor-1 in cancer cells
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 23, Issue 5, Pages 447-456
Publisher
Informa UK Limited
Online
2019-04-02
DOI
10.1080/14728222.2019.1602608
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Production and evaluation of a 67Ga-labeled anti-Ror1 monoclonal antibody in a mouse model of breast cancer
- (2018) Saeideh Milani et al. JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY
- A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinib
- (2018) Amir Hossein Daneshmanesh et al. PLoS One
- Potent and selective antitumor activity of a T cell-engaging bispecific antibody targeting a membrane-proximal epitope of ROR1
- (2018) Junpeng Qi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Management of Brain Metastases in Tyrosine Kinase Inhibitor–Naïve Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis
- (2017) William J. Magnuson et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
- (2017) Justin Eyquem et al. NATURE
- MicroRNAdysregulation to identify therapeutic target combinations for chronic lymphocytic leukemia
- (2017) Laura Z. Rassenti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An ROR1 bi-specific T-cell engager provides effective targeting and cytotoxicity against a range of solid tumors
- (2017) Satyen Harish Gohil et al. OncoImmunology
- Chimeric antigen receptor T cell therapy: 25years in the making
- (2016) Saar Gill et al. BLOOD REVIEWS
- Cancer immunotherapy: the beginning of the end of cancer?
- (2016) Sofia Farkona et al. BMC Medicine
- Cirmtuzumab inhibits Wnt5a-induced Rac1 activation in chronic lymphocytic leukemia treated with ibrutinib
- (2016) J Yu et al. LEUKEMIA
- Expression of ROR1, pAkt, and pCREB in gastric adenocarcinoma
- (2015) Hyeyoon Chang et al. Annals of Diagnostic Pathology
- CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
- (2015) S. L. Maude et al. BLOOD
- Pre-clinical Specificity and Safety of UC-961, a First-In-Class Monoclonal Antibody Targeting ROR1
- (2015) Michael Y. Choi et al. Clinical Lymphoma Myeloma & Leukemia
- Receptor tyrosine kinase-like orphan receptor 1: a novel target for cancer immunotherapy
- (2015) Mahdi Shabani et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer
- (2015) HONG TAN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation
- (2015) Jian Yu et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion
- (2015) Claire Henry et al. Oncotarget
- Silencing of Receptor Tyrosine Kinase ROR1 Inhibits Tumor-Cell Proliferation via PI3K/AKT/mTOR Signaling Pathway in Lung Adenocarcinoma
- (2015) Yanchun Liu et al. PLoS One
- IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas
- (2015) Xin Huang et al. PLoS One
- Clinicopathological Significance of MicroRNA-214 in Gastric Cancer and Its Effect on Cell Biological Behaviour
- (2014) Ya-Wen Wang et al. PLoS One
- Evolutionary Divergence in the Catalytic Activity of the CAM-1, ROR1 and ROR2 Kinase Domains
- (2014) Travis W. Bainbridge et al. PLoS One
- ROR1, an embryonic protein with an emerging role in cancer biology
- (2014) Nicholas Borcherding et al. Protein & Cell
- Safety of Targeting ROR1 in Primates with Chimeric Antigen Receptor-Modified T Cells
- (2014) C. Berger et al. Cancer Immunology Research
- Targeting ROR1 Inhibits Epithelial-Mesenchymal Transition and Metastasis
- (2013) B. Cui et al. CANCER RESEARCH
- Receptor Affinity and Extracellular Domain Modifications Affect Tumor Recognition by ROR1-Specific Chimeric Antigen Receptor T Cells
- (2013) M. Hudecek et al. CLINICAL CANCER RESEARCH
- Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report
- (2013) A. Wesley Burks et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity
- (2013) Cor HJ Lamers et al. MOLECULAR THERAPY
- Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors
- (2013) James N. Kochenderfer et al. Nature Reviews Clinical Oncology
- Inhibition of the Receptor Tyrosine Kinase ROR1 by Anti-ROR1 Monoclonal Antibodies and siRNA Induced Apoptosis of Melanoma Cells
- (2013) Mohammad Hojjat-Farsangi et al. PLoS One
- ROR1 can interact with TCL1 and enhance leukemogenesis in E -TCL1 transgenic mice
- (2013) G. F. Widhopf et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The molecular basis of targeting protein kinases in cancer therapeutics
- (2013) Chung-Jung Tsai et al. SEMINARS IN CANCER BIOLOGY
- From "magic bullets" to specific cancer immunotherapy
- (2013) C Riether et al. SWISS MEDICAL WEEKLY
- Generation of more effective cancer vaccines
- (2013) Daniela Fenoglio et al. Human Vaccines & Immunotherapeutics
- The Onco-Embryonic Antigen ROR1 Is Expressed by a Variety of Human Cancers
- (2012) Suping Zhang et al. AMERICAN JOURNAL OF PATHOLOGY
- Crosstalk between ROR1 and the Pre-B Cell Receptor Promotes Survival of t(1;19) Acute Lymphoblastic Leukemia
- (2012) Vincent T. Bicocca et al. CANCER CELL
- NKX2-1/TITF1/TTF-1-Induced ROR1 Is Required to Sustain EGFR Survival Signaling in Lung Adenocarcinoma
- (2012) Tomoya Yamaguchi et al. CANCER CELL
- Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells
- (2012) A H Daneshmanesh et al. LEUKEMIA
- ROR1 Is Expressed in Human Breast Cancer and Associated with Enhanced Tumor-Cell Growth
- (2012) Suping Zhang et al. PLoS One
- Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
- (2011) R. J. Brentjens et al. BLOOD
- Ror1 Is a Pseudokinase That Is Crucial for Met-Driven Tumorigenesis
- (2011) A. Gentile et al. CANCER RESEARCH
- CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients
- (2011) Barbara Savoldo et al. JOURNAL OF CLINICAL INVESTIGATION
- Use of the receptor tyrosine kinase-like orphan receptor 1 (ROR1) as a diagnostic tool in chronic lymphocytic leukemia (CLL)
- (2011) Sabrina Uhrmacher et al. LEUKEMIA RESEARCH
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic Potential and Challenges of Targeting Receptor Tyrosine Kinase ROR1 with Monoclonal Antibodies in B-Cell Malignancies
- (2011) Jiahui Yang et al. PLoS One
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
- (2011) M. Kalos et al. Science Translational Medicine
- MicroRNAs: Synthesis, mechanism, function, and recent clinical trials
- (2010) Fazli Wahid et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor
- (2010) M. Hudecek et al. BLOOD
- Silencing of ROR1 and FMOD with siRNA results in apoptosis of CLL cells
- (2010) Aniruddha Choudhury et al. BRITISH JOURNAL OF HAEMATOLOGY
- Targeting inhibitory pathways in cancer immunotherapy
- (2010) Marcio O Lasaro et al. CURRENT OPINION IN IMMUNOLOGY
- ROR1 expression is not a unique marker of CLL
- (2010) Gábor Barna et al. HEMATOLOGICAL ONCOLOGY
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
- (2010) Richard A Morgan et al. MOLECULAR THERAPY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- miR-15a and miR-16-1 in cancer: discovery, function and future perspectives
- (2009) R I Aqeilan et al. CELL DEATH AND DIFFERENTIATION
- Unique Cell Surface Expression of Receptor Tyrosine Kinase ROR1 in Human B-Cell Chronic Lymphocytic Leukemia
- (2008) S. Baskar et al. CLINICAL CANCER RESEARCH
- Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a
- (2008) T. Fukuda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now